Cargando…
Incorporation of α2-Plasmin Inhibitor into Fibrin Clots and Its Association with the Clinical Outcome of Acute Ischemic Stroke Patients
Cross-linking of α2-plasmin inhibitor (α2-PI) to fibrin by activated factor XIII (FXIIIa) is essential for the inhibition of fibrinolysis. Little is known about the factors modifying α2-PI incorporation into the fibrin clot and whether the extent of incorporation has clinical consequences. Herein we...
Autores principales: | Bagoly, Zsuzsa, Baráth, Barbara, Orbán-Kálmándi, Rita, Szegedi, István, Bogáti, Réka, Sarkady, Ferenc, Csiba, László, Katona, Éva |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7996613/ https://www.ncbi.nlm.nih.gov/pubmed/33669007 http://dx.doi.org/10.3390/biom11030347 |
Ejemplares similares
-
A modified in vitro clot lysis assay predicts outcomes and safety in acute ischemic stroke patients undergoing intravenous thrombolysis
por: Orbán-Kálmándi, Rita, et al.
Publicado: (2021) -
Low α2-Plasmin Inhibitor Antigen Levels on Admission Are Associated With More Severe Stroke and Unfavorable Outcomes in Acute Ischemic Stroke Patients Treated With Intravenous Thrombolysis
por: Székely, Edina Gabriella, et al.
Publicado: (2022) -
Decreased clot burden is associated with factor XIII Val34Leu polymorphism and better functional outcomes in acute ischemic stroke patients treated with intravenous thrombolysis
por: Szegedi, István, et al.
Publicado: (2021) -
A Modified in vitro Clot Lysis Assay Predicts Outcomes in Non-traumatic Intracerebral Hemorrhage Stroke Patients—The IRONHEART Study
por: Orbán-Kálmándi, Rita, et al.
Publicado: (2021) -
Stroke as a Potential Complication of COVID-19-Associated Coagulopathy: A Narrative and Systematic Review of the Literature
por: Szegedi, István, et al.
Publicado: (2020)